Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study led by Professor Seena Fazel at the University of Oxford found that among patients with chronic, non-communicable diseases, the risk of death is more than doubled if they also have a psychiatric disease.

Stethoscope and keyboard

The study, published in PLOS Medicine, included national registers in Sweden to investigate more than one million patients who had diagnoses of chronic respiratory disease, cardiovascular disease, and diabetes. More than a quarter (25-32%) of people in the analysis had a co-occurring lifetime diagnosis of any psychiatric disorder.

Non-communicable diseases, such as diabetes and heart disease are a global public health challenge accounting for an estimated 40 million excess deaths annually.

Professor Seena Fazel, Department of Psychiatry, University of Oxford, said:


'This adds to the emerging evidence that improving assessment, treatment, and follow-up of people with comorbid psychiatric disorders will reduce mortality and suicide risk in people with chronic non-communicable diseases.'

Within five years of diagnosis, at least 7% of the people included in the study had died from any cause and 0.3% had died from suicide. Comorbid (two or more diseases in a patient) psychiatric disorders were associated with higher all-cause mortality (15.4%-21.1% over five years) when compared to those without such conditions (5.5%-9.1%).

When the researchers compared each patient with an unaffected sibling, who did not have the chronic health condition, so as to account for risk factors shared within families, such as early environment and genes, psychiatric comorbidity remained consistently associated with elevated rates of premature mortality and suicide. Risks ranged by psychiatric diagnosis; for instance, mortality risks were elevated by up to nine times in those with comorbid substance use disorder compared to unaffected siblings, and by up to seven times in those with comorbid depression.

One study limitation is that the use of population-based registries to identify patients meant that psychiatric comorbidities were diagnosed in outpatient and hospital settings and those with less severe psychiatric disorders could be missed.

Overall the findings point towards better integration of services for chronic physical, mental health and substance use services, and underscore the importance or primary care in the early diagnosis and treatment of psychiatric disorders.

Similar stories

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Unique study of vascular disease reaches 20th anniversary

The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.

DPAG launches “Body, Brain, Behavior: Three Views and a Conversation” in Oxford

The Oxford Book Launch 'Body Brain Behavior - The Need For Conversations' brought together three world leading scientist authors, Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch, with Oxford's neuroscience community on Thursday 7 April 2022.

Little understood brain region linked to how we perceive pain

A new review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.